Submit ICO / Airdrop ★ Get Promotion

ICOmarks
ICOs
Covi19

Covi19

ICO Ended

2,765 Views

Visit Website
Last screenshot taken on
13 Jul 2021 .

Add to Watchlist

CORONA (COVI19) Token is a new generation DeFi (Multichain) project that combines a decentralized cryptocurrency exchange, an automatic market maker protocol (AMM), a yield farming platform, and even an NFT marketplace. CORONA (COVI19) Token allows quick expansion of this range by adding new pools, new farms, partner projects, and even completely new spheres of activity. The goal of the CORONA (COVI19) Token team is to create an ecosystem that can offer any DeFi enthusiast a way to generate income that is suitable for them. CORONA (COVI19) Token is also involved in profitable farming, the profit from which is distributed among all participants of the project's pools and farms, providing them with an additional source of income. The token burning mechanism protects farmers from market-induced risks. Removing the Migrator function and implementing a Timelock of 24 hours removes entirely the risk of a rug pull as we want CORONA (COVI19) Token farmers to farm without risks.

Charity

4.4

TOTAL SCORE

5.4

ICO PROFILE

(weight: 45%)

1

TEAM PROOF

(weight: 20%)

Get widget

General

Website: Visit

White paper: Read

ICO Time: 14 June 2021 - 15 Sept 2021

Token info

Ticker: COVI19

Platform: Binance Chain

Token Type: BEP 20

Available for sale: 750,000,000 COVI19 (15%)

Financial

Pre-sale Price : 1 BNB = 100000 Covi19

Accepting: BTC, ETH

Social media

Facebook

Twitter

Telegram

Github

Medium

Linkedin

2021 Q3

Concept<br /> Concept and Designing<br /> Initial Architecture<br /> Website designing<br />

2021 Q4

Research<br /> Tokenomics<br /> White paper completion<br /> Initial Release<br /> (Initial Token burn)<br /> BSC Scan Approval<br /> Visualisation of Platform design and technical demonstartion for the user convenience<br /> Strategic Plan<br /> Public financing & Seed funding raised<br /> Social media platform marketing campaigns<br /> Initiate discussions with Covid 19 charitable organizations to enhance awareness<br />

2022 Q1

Design<br /> Approaching DEX trading platforms such as<br /> Coin Marketplace<br /> CoinGeko<br /> Bitmart<br /> Approaching Covid Support center for charity<br /> Manual Token Burn<br /> Transfer fund to charity foundation

HORIZONTAL

SQUARE

HEIGHT - 0px

WIDTH - 0px

PUT THIS CODE TO YOUR WEBSITE

Other Interesting ICOs

"People can, DAO's do. Candao mission is to create a platform where individuals with the same business and social goals can come together to inspire, engage and build values together. Candao unlock people’s superpowers and let them tokenize the value they create, liquefy assets, connect existing ones, bring people together in order to build joint ventures, distribute profits between all involved people and unlock the value of everyone who plays different roles in everyday life."

At its core, Nice 1 is a blockchain game development platform. When using Nice 1, a game developer can raise funds from public and private supporters. However, Nice 1 goes further than just mere fundraising. The Nice 1 blockchain provides users with access to an SDK library (and documentation) for Unreal Engine & Unity. Nice 1 is striving to create state-of-the-art gaming services for streamers and esports enthusiasts. Non-game developers can earn and support gamers and developers, by helping support the Nice 1 blockchain network. The primary goal of Nice 1, is to promote innovation in gaming worldwide. However, in the process, Nice 1 is also striving to tackle increasing censorship in gaming.

The Natural Asset Exchange blockchain platform and Earth Token cryptocurrency initial coin offering (ICO) token sale provides a unique opportunity to truly transform the Natural Capital Asset market, by creating a Natural Asset Marketplace that allows all stakeholders in the climate value chain to participate.

Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.

ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.